Streetbeat News

Stock Prices

ANIX

Anixa Biosciences presented its ovarian cancer CAR-T therapy at the Rivkin Center-AACR 15th Biennial Ovarian Cancer Research Symposium, highlighting advancements in cancer treatment.

Portfolio Pulse from Benzinga Newsdesk

September 03, 2024 | 12:34 pm

BTCUSD

QCP Capital highlights a potential bullish trend for Bitcoin in October, with historical data showing positive returns in eight of the last nine years. Despite a recent 6.7% drop in Bitcoin's price, macroeconomic factors like potential interest rate cuts could boost Bitcoin's value.

Portfolio Pulse from Murtuza Merchant

September 03, 2024 | 12:33 pm

GIFT

RDE has announced a change in its NASDAQ ticker symbol from RSTN to GIFT. This change is effective immediately and reflects the company's rebranding efforts.

Portfolio Pulse from Benzinga Newsdesk

September 03, 2024 | 12:31 pm

PWUPU

Trading halt status was updated at 8:30 AM ET, indicating a resumption of quotations. The article may mention PWUPU, which could be relevant for investors tracking this asset.

Portfolio Pulse from Benzinga Newsdesk

September 03, 2024 | 12:30 pm

APEI

BEN

INBX

OLED

The article highlights notable insider trades in four companies: American Public Education, Inhibrx Biosciences, Franklin Resources, and Universal Display. Insider purchases can indicate confidence in a company's prospects. Franklin Resources saw a significant purchase by a 10% owner, while other companies also had insider buying despite mixed financial results.

Portfolio Pulse from Avi Kapoor

September 03, 2024 | 12:28 pm

PWUP

The trading halt status was updated at 8:25 AM ET, indicating a quotation resumption. This update is relevant for investors tracking trading activities and potential impacts on stock prices.

Portfolio Pulse from Benzinga Newsdesk

September 03, 2024 | 12:25 pm

KROS

Keros Therapeutics has closed screening for its Phase 2 TROPOS trial of cibotercept in patients with pulmonary arterial hypertension, expecting to complete enrollment by September and present data in Q2 2025.

Portfolio Pulse from Benzinga Newsdesk

September 03, 2024 | 12:24 pm

PASG

Passage Bio shares increased after Rodman & Renshaw initiated coverage with a Buy rating and a $7 price target.

Portfolio Pulse from Benzinga Newsdesk

September 03, 2024 | 12:24 pm

PHGE

BiomX Inc. (NYSE:PHGE) will present data from its Phase 1b/2a study of BX004, a phage therapy for cystic fibrosis patients, at the ERS Congress 2024. The study shows promising safety and efficacy results.

Portfolio Pulse from Benzinga Newsdesk

September 03, 2024 | 12:23 pm

AUUD

Auddia shares rose following the launch of Apple CarPlay and Android Auto interfaces for its faidr mobile app.

Portfolio Pulse from Benzinga Newsdesk

September 03, 2024 | 12:23 pm